Changes in Psychological Burden and Quality of Life During In Vivo Diagnostic Evaluation for Immediate Drug Hypersensitivity: A Prospective Stepwise Study
Background/Objective: The psychological impact of in vivo diagnostic procedures remains poorly understood. We assessed changes in psychological distress and drug hypersensitivity-related quality of life (QoL) throughout a diagnostic evaluation for suspected immediate drug hypersensitivity reactions (IDHRs) and aimed to identify predictors of persistent psychological burden. Methods: This single-center prospective observational longitudinal study included 100 consecutive adults undergoing evaluation for suspected IDHRs. Psychological distress and QoL were assessed using the Depression Anxiety Stress Scale-21 (DASS-21) and the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q). Assessments were performed before and after each diagnostic phase, including skin tests (STs), placebo, and drug provocation tests (DPTs). Results: The mean age was 44.2 ± 12.5 years, and women comprised 72% of the cohort. Depression, anxiety, stress, and DrHy-Q scores significantly decreased after ST, placebo, and DPT compared with baseline measurements. Across diagnostic stages, depression, anxiety, stress, and DrHy-Q scores were significantly lower during the DPT phase than during the ST and placebo phase in both pre-test and post-test measurements (p < 0.01 for pairwise comparisons). The number of prior HSRs showed a weak but significant positive correlation with DrHy-Q scores. In multivariable linear regression analysis, the number of prior HSRs was the only independent predictor of post-DPT DrHy-Q scores (β = 3.43, 95% CI 1.36–5.50, p = 0.001). Patients who avoided the provoked drug despite a negative DPT had higher DPT-post depression, anxiety, stress, and DrHy-Q scores. Conclusions: Psychological burden progressively decreased over the course of the stepwise diagnostic evaluation for suspected IDHRs, although patients with repeated reactions may benefit from additional support.
Authors
- Ayse Feyza Aslan (ORCID: https://orcid.org/0000-0001-5866-2646)
- Pelin Korkmaz (ORCID: https://orcid.org/0000-0002-0225-2485)
- Yavuz E. Kesgin
- Semra Demir (ORCID: https://orcid.org/0000-0003-3449-5868)
- Osman Ozan Yeğit (ORCID: https://orcid.org/0000-0003-4256-6048)
- Şule Çelik Kamacı (ORCID: https://orcid.org/0000-0001-7132-2400)
- Deniz Eyice Karabacak (ORCID: https://orcid.org/0000-0001-7627-8621)
- Andaç Karadeniz (ORCID: https://orcid.org/0000-0002-4796-3328)
- Derya Ünal (ORCID: https://orcid.org/0000-0001-9741-5939)
- Nevzat Kahveci (ORCID: https://orcid.org/0000-0003-0841-8201)
- Asli Akkor Gelincik (ORCID: https://orcid.org/0000-0002-3524-9952)
- İlkim Deniz Toprak (ORCID: https://orcid.org/0000-0002-9320-1252)
- Esra Kaya
- Selin Ece Guzel
- Merve Dilsad Atasever
- Leyla Bolek
- Bircan Erden (ORCID: https://orcid.org/0009-0003-2943-4697)
- Mehmet Emin Sezgin (ORCID: https://orcid.org/0000-0002-7654-283X)
- Merve Hörmet İğde
Institutions
- Istanbul University (TR)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-10-15
- DOI
- https://doi.org/10.3390/jcm15207964
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00